January 2016

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


Ongoing All Ranks Non-federal Culture of Health

Robert Wood Johnson Foundation (RWJF)
Evidence for Action: Investigator-Initiated Research to Build a Culture of Health

Development of data and evidence needed to advance a Culture of Health.  Research could: (1) Provide evidence for factors in the Action Framework that are believed - but not yet proven to impact health; (2) Reframe or challenge existing ideas; (3) Integrate existing data and methods across disciplines and sectors; and/or (4) Identify actions that can improve health for marginalized populations.
Due Dates: Applicants can expect notification w/in 6-8 weeks of a 2-page Letter of Intent submission. Invited applicants will have 2 months to submit a proposal notified. Funding decisions will generally be made within 6-8 weeks of the full submission.
Amount & Project Period: ~$200,000 - up to 30 months
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Links: Overview Ι 2015 Call For Proposals

Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding.
Due Dates: Open until Mar. 31, 2017
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03


Ongoing All Ranks Federal See BAA

United States Army Medical Research and Materiel Command (USAMRMC)Broad Agency Announcement for Extramural Medical Research
W81XWH-16-R-BAA1

The mission of the USAMRMC is to provide solutions to medical problems of importance.  Projects must be for basic and applied research. Projects must be for scientific study and experimentation directed toward advancing the state of the art or increasing knowledge or understanding.  (See general description of research and development programs, including research areas of interest in the announcement.)
Due Dates: Open continuously from Oct. 01, 2015 through Sept. 30, 2016. Organizations are required to submit pre-proposals/pre-applications. 
Amount & Project Period: Budgets are not limited - up to 5 years
Eligibility: All individuals, regardless of ethnicity, nationality, or citizenship status, employed by, or affiliated with, an eligible organization
Contact: Linda Nolan (x6071)
Link: W81XWH-16-R-BAA1


Ongoing All Ranks Non-federal Macroglobulinemia

International Waldenstrom's Macroglobulinemia Foundation
Research Grants

To further scientific knowledge of the cause, diagnosis, treatment, or cure for the disease Waldenstrom's Macroglobulinemia, a type of non-Hodgkin's Lymphoma also called lymphoplasmacytic lymphoma.
Due Dates: Ongoing
Amount & Project Period: $50,000 to $100,000 - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Link: Guidelines

NEW
December 30 Female Postdocs Non-federal Women's Health

American Fund for Alternatives to Animal Research (afaar)
Fellowship Grant for Alternatives to Animal Research  in Women's Health and Sex Differences

The fellowship will be awarded to a woman interested in developing, validating, or using alternatives to animal methods in the investigation of women's health or sex differences.
Due Dates: Dec. 28 (OSR) Ι Dec 30. (Sponsor)
Amount & Project Period: $40,000 - 1 year
Eligibility: Postdoctoral female scientists researching women's health or sex differences whose research involves development, validation, or use of non-animal alternatives.
Contact: Linda Nolan (x6071)
Links: How to Apply  Ι afaar
R50 NIH

NEW

Limited Submission Opportunity
December 31, 1:00pm Research Scientists Federal Career Development

NCI Research Specialist Award

NCI has announced a Research Specialist Award in any area of cancer research.  This award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to pursue research within the context of an existing cancer research program, but not serve as independent investigators.  These scientists, such as researchers within a research program, core facility managers, and data scientists, are vital to sustaining the biomedical research enterprise.  
Due Dates: An internal Moffitt review will be conducted.  A full draft letter of intent and a current NIH biosketch is due by Dec. 31, 2015 by 1:00 pm. Please submit in PDF format to Sandy.Moore@moffitt.org .
    
Jan. 9, 2016 (Letter of Intent due at NCI)
Approved Applications Due:  Feb. 07 (OSR) Ι Feb. 09 (Sponsor)
Amount & Project Period: Application budgets may request the following two expenses in direct costs per year:
1) up to 100% salary support (not to exceed the NIH Legislatively-mandated Salary Cap) for the Research Specialist and commensurate with their level of effort on NCI-funded research grants; and
2) travel costs to attend research meetings/conferences not to exceed $5,000 per year.
Eligibility: A Research Specialist must have:        
An advanced degree (e.g. Masters, PhD, DVM, DDS or MD) in an area of biomedical science or engineering.
Have demonstrated research accomplishments in their primary discipline.
At the time of award, the Research Specialist must have a full-time appointment at the academic or research institution.
The Research Specialist is required to commit a minimum of 50% of full-time professional effort (i.e., a minimum of 6 person-months) on NCI-funded research. The Research Specialist may engage in other duties as part of the remaining 50% of their full-time professional effort not covered by this award.
The Research Specialist should have demonstrated professional accomplishments consonant with his or her career status, and should have demonstrated cancer research experience in the areas of behavioral, biomedical (basic or clinical), computational or bioengineering research that is relevant to the NCI mission.
The award is intended for cancer research-oriented investigators with significant, relevant experience, who have shown clear evidence of productivity and research excellence in the field of their training, and who would like to support a cancer research program, with the goal of continuing to make significant contributions to cancer research in the areas of behavioral, biomedical (basic or clinical), computational or bioengineering research that is relevant to the NCI mission.
Contacts: Regarding the internal review:   Maureen.Ahearn@moffitt.org/ (12/21-24) and Brian.Springer@moffitt.org (12/28 -30) Regarding funding opportunity:  Margaret.fonner@moffitt.org or Christina.craig@moffitt.org
FOA Link: PAR-16-025


NEW
January 04 All Faculty Non-federal Afatinib

NCCN Afatinib Combination Research Grant Opportunity

To support NCCN investigator initiated studies for the performance of preclinical, clinical, and correlative studies of afatinib containing combinations in the treatment of lung and head and neck cancers.   The motivation behind this RFP is to facilitate development of combination therapies using afatinib.  Towards this goal, several specific additional therapies may be available from collaborating pharmaceutical companies, and are detailed in the RFP, though investigations addressing any combination regimens will be considered.
Due Dates: Dec. 31 (OSR) Ι Jan. 04 (Sponsor) 
Proposals are required to be submitted electronically to the NCCN research portal at https://www.mednetstudy.com/sgs/nccn/.
Amount & Project Period: Funding should not exceed $600,000 (TOTAL). Clinical study maximum $300,000 + correlative study maximum $200,000 + multi-institutional funding maximum $100,000 = $600,000 MAXIMUM funding.
Eligibility: All Faculty 
Contact: Linda Nolan (x6071)
Links:  RFP | NCCN Oncology Research Program (ORP)
R01 NIH
NCI is a participating institute
NEW
January 04 (LOI) Junior Faculty Federal Tobacco Regulatory Science

Tobacco Regulatory Science Small Grant Program for New Investigators

Applicants are encouraged to conduct projects that ultimately have potential to inform regulations on tobacco product manufacturing, distribution, and marketing.
Due Dates: Jan. 4 (Letter of Intent)
Applications due:  Feb. 21 (OSR) | Feb. 23 (Sponsor)
Amount & Project Period: Limited to $75,000/yr. (Direct Costs) - 2 years
Eligibility: Only New Investigators who fit the criteria in this section are eligible.  Excluded from consideration are individuals who have received the following from any NIH Institute or Center: Pathway to Independence Award-Research Phase (R00);  Small Grant (R03) support in Tobacco Regulatory Science; or Exploratory/Developmental Grant (R21) in Tobacco Regulatory Science
Contact: Linda Nolan (x6071)
RFA Link: RFA-OD-15-004


NEW
January 07 (Noon, EST) Postdocs Non-federal   Career Development

AACR Clinical and Translational Cancer Research Fellowships

To conduct clinical and/or translational cancer research. Proposed research projects may be in any area of clinical and/or translational cancer research.
Due Dates: Jan. 05 (OSR) Ι Jan. 07 (Sponsor) (Noon, EST)
Amount & Project Period: $55,000 - 1 year
Eligibility: Hold full-time, mentored research position w/title of postdoctoral fellow, clinical research fellow, or equivalent
     If eligibility based on a future position, position must be
     confirmed at time of application, and can NOT be contingent  
     upon receiving this grant.
Completed most recent doctoral degree w/in past 5 years (i.e., degree cannot have been conferred before July 2, 2011) Applicant w/medical degree must have completed most recent doctoral degree or medical residency - whichever date is later - w/in past 5 years.
Work under the auspices of a mentor at an academic, medical, or research institution.
AACR membership is required; must submit a satisfactory application for AACR Associate Membership by Thursday, January 7, 2016.
Contact: Linda Nolan (x6071)
Links: 2016 Program Guidelines and Application Instructions
ProposalCENTRAL (Submission Site)

NEW
January 07 (LOI) All Ranks Non-federal Breast

Avon Foundation for Women
Research Grants

 This program funds translational research using clinical studies, human cell culture, epidemiologic and other progressive approaches to understand the causes of breast cancer and develop new treatments.   Supports research projects aimed at understanding the causes of breast cancer, prevention or developing new treatments for metastatic breast cancer.
Due Dates: Jan. 07 (Letter of Intent)
Invited Submissions:  Jul. 09 (OSR) Ι Jul. 11 (Sponsor)
Amount & Project Period: Up to $150,000/yr. (TOTAL) - 2 years
Eligibility: All Ranks
Contact: Mary Newton (x3672) at Moffitt Foundation for writing assistance
Link: 2016 Program Guidelines Ι Request for Proposals
UG3/UH3 NCI

January 09 (LOI) All Ranks Federal Cancer Detection

Cancer Detection, Diagnosis, and Treatment Technologies for Global Health

Supports development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs).  Specifically seeking projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for imaging, detecting, diagnosing, preventing, and/or treating cancers in humans living in LMICs.
Due Dates: Jan. 09 (Letter of Intent)
Applications due:  Feb. 07 (OSR) Ι Feb. 09 (Sponsor)  
Amount & Project Period: $325,000/yr. (Direct Costs) for UG3 phase - 2 years max. $650,000/yr. (Direct Costs) for UH3 phase - 3 years max.
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-024
R21/R03 NIEHS/NCI

National Institute of Environmental Health Sciences and National Cancer Institute
 
January 10 (LOI) All Ranks Federal Breast Cancer & Environment

Breast Cancer and the Environment Communication Research Initiative

Supports research on behavioral uptake of risk messaging and individual behavioral change. May also be utilized to explore implementation of existing risk messages and whether such messaging has affected policy change or large scale systemic changes to reduce the sources of pollution that pose a risk for breast cancer.
Due Dates: Jan. 10 (Letter of Intent)
Applications due: Feb. 08 (OSR) Ι Feb. 10 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-ES-15-017
Companion RFA: RFA-ES-15-0-15 (R03)
R03 NIH
Common Fund initiative
Administered by NCI
January 11 (LOI) All Ranks Federal Metabolomics

Metabolomics Data Analysis

To foster collaboration between bioinformaticians, metabolomics experts, and/or biomedical researchers in efforts to improve the ability to analyze metabolomics data to address biomedical questions.
Due Dates: Jan. 11 (Letter of Intent)
Applications due: Feb. 09 (OSR) Ι Feb. 11 (Sponsor)
Amount & Project Period: $100,000 - 1 year
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-RM-15-021

NEW
January 11 (2:00pm, EST) Pre-doctoral Students Non-federal Career Development

Howard Hughes Medical Institute
Medical Research Fellowships

The program is designed to give students the opportunity to immerse themselves in a year of basic, translational, or applied biomedical research, during which they will become part of a community of medical fellows through regional meetings and other events.
Due Dates: Jan. 07 (OSR) Ι Jan. 11 (Sponsor) (2:00pm, EST)
Amount & Project Period: Stipend:                         $30,000
Research Allowance:  $5,500 (Investigator mtgs., scientific conferences, research-related books and some research-related costs)
Fellow's Allowance:    $5,500 (e.g. health, dental, vision insurance; education-related expenses)  
Eligibility: Must be in good standing at a U.S. medical, dental, or veterinary school.
U.S. citizenship is not required.
Cannot be enrolled in a combined medical, dental, or veterinary/PhD program (e.g., MD/PhD) or PhD, or ScD program, or have a PhD or ScD in a laboratory-based biological science. Previous laboratory research experience is required. Applicants should have one or more substantial research experiences (e.g., summer or part-time).
Fellows must engage in research full-time during the fellowship term
Contact: Linda Nolan (x6071)
Links: Medical Research Fellows Program
Application submission: www.hhmi.org/competitions




NEW
January 12 (Noon, EST) All Ranks Non-federal Kidney Cancer

Kure It-AACR
Research Grant for Immunotherapy in Kidney Cancer

To study immunological aspects of, or treatments for, kidney cancer.  Research projects should advance the basic knowledge of tumor immunology mechanisms, or develop new concepts in the treatment, control, or prevention of kidney cancer by immunology-based therapeutic approaches.
Due Dates: Jan. 10 (OSR) Ι Jan. 12 (Sponsor) (Noon, EST)
Amount & Project Period: $125,000/yr. - 2 years
Eligibility: Must have doctoral degree in a related field and
Must be an independent investigator (all levels)
AACR membership is required Nonmembers must submit application for Active Membership by January 12th.
Contact: Linda Nolan (x6071)
Links: Application Instructions Ι Proposal CENTRAL (Submission Site)




NEW
January 12 (Noon, EST) All Faculty Non-federal Neuroendocrine Tumors

Neuroendocrine Tumor Research Foundation-AACR
Research Grant

To develop and study new ideas and innovative approaches having direct application and relevance to neuroendocrine tumors.  Proposed research may be in any discipline of basic, translational, clinical, or epidemiological cancer research.
Due Dates: Jan. 10 (OSR) Ι Jan. 12 (Sponsor) (Noon, EST)
Amount & Project Period: $125,000/yr. - 2 years
Eligibility: Must have doctoral degree in a related field and
Must be an independent investigator (all levels)
AACR membership is required Nonmembers must submit application for Active Membership by January 12th.
Contact: Linda Nolan (x6071)
Links: Application Instructions Ι Proposal CENTRAL (Submission Site)

NEW
January 13 (1:00pm, EST) Postdocs Non-federal Career Development

American Brain Tumor Association
Basic Research Fellowship Program

The award provides support for basic research projects that have significant potential to advance our understanding of the causes, effects, diagnosis and treatment of brain tumors.
Due Dates: Jan. 11 (OSR) Ι Jan. 13 (Sponsor) (1:00pm, EST)
Amount & Project Period: $100,000 - 2 years  
Eligibility: Must have a doctoral degree, and be no more than 4 years post-completion of degree.
MDs must be no more than 4 years post-residency training. Candidate must commit at least 75% effort to the research project during each year of the grant.
Candidate must include a Lead Mentor who currently conducts brain tumor research at the same academic institution. Candidate is not required to be a U.S. citizen or resident
Contact: Linda Nolan (x6071)
Links: RFA Ι ABTA grant portal
R01 NHGRI

January 14 All Ranks Federal Genomic Technology

Novel Genomic Technology Development

Initiative seeks to optimize innovation, insight and cutting edge conceptual and technological breakthroughs by catalyzing research that emanates from the identified innovative questions in symptom and genomic nursing science. These innovative questions are reflective of broad domains from which more specific novel hypotheses or problems to be solved can be derived.
Due Dates: Jan. 12 (OSR) Ι Jan. 14 (Sponsor)
Amount & Project Period: $700,000/yr. (Direct Costs) - 4 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-16-014
Companion FOAs: PAR-16-015 (R21)
PAR-16-016 (R43/R44)
PAR-16-017 (R44)

NEW
January 14 All Ranks Non-federal Toxicology

Medical Toxicology Foundation
Research and Teaching Awards

This initiative funds innovative projects that advance the foundation's mission to sustain and improve the practice of medical toxicology, enhance patient care, and improve the dissemination of knowledge regarding toxic exposures.
Due Dates: Jan. 12 (OSR) Ι Jan. 14 (Sponsor)
Amount & Project Period: $5,000-$20,000 to support projects of 1-2 years
Eligibility: Must be a member in good standing of the American College of Medical Toxicology (ACMT).
PI or Senior Investigator must be an active ACMT member.
Co-Investigators are not required to be ACMT members.
Contact: Linda Nolan (x6071)
Links: Application materials can be found here.
American College of Medical Toxicology
Medical Toxicology Foundation












January 15 All Ranks Non-federal Gastrointestinal

American Gastroenterological Association Research Awards

AGA-Elsevier Pilot Research Award

Supports pilot research projects in gastroenterology-or hepatology-related areas.
Due Dates:

Jan. 13 (OSR) Ι Jan. 15 (Sponsor)

Amount & Project Period: $25,000 - 1  year
Eligibility: All Ranks - must hold an MD, PhD or equivalent degree and a fulltime faculty appointment.
AGA Membership is required.
Contact: Linda Nolan (x6071)
Link: Guidelines

AGA-Elsevier Gut Microbiome Pilot Research Award

Opportunity offered to early stage and established investigators to support pilot research projects pertaining to the gut microbiome.
Due Dates:

Jan. 13 (OSR) Ι Jan. 15 (Sponsor)

Amount & Project Period: $25,000 - 1  year
Eligibility: All Ranks - must hold an MD, PhD or equivalent degree and a fulltime faculty appointment.
AGA Membership is required.
Contact: Linda Nolan (x6071)
Link: Guidelines

January 15 (3:00PM  ET) Postdocs Non-federal Career Development

Lymphatic Education & Research Network
Postdoctoral Fellowship Awards Program

Research areas of interest include lymphatic vessel biology and pathology; physiological mechanisms of normal and pathological lymphangiogenesis; animal models of the lymphatic system and its disorders; studies (including lymphatic imaging) that address regulation of lymphatic structure and function.
Due Dates: Jan. 13 (OSR) Ι Jan. 15 (Sponsor)
Amount & Project Period: $87,396 - $98,304 - 2 years
Eligibility: Must hold a PhD and/or MD or equivalent degree and have completed <3 years of full-time postdoctoral research experience by July 1, 2016. 
Contact: Linda Nolan (x6071)
Links: Overview Ι Postdoctoral Awards Program



January 15 (Noon, EST) Clinical Faculty Non-federal Pancreatic - Clinical Trials

2016 Pancreatic Cancer Action Network -
Research Acceleration Network  (RAN) Grant

Funding for research in pancreatic cancer that includes a clinical project with an endpoint that improves prevention, detection/diagnosis/ prognosis, treatment or supportive care.  Clinical component must be implemented no later than beginning of last year of grant term.
Due Dates: Jan. 13 (OSR) Ι Jan. 15 (Sponsor) (Noon, EST)
Amount & Project Period: $1,000,000 (TOTAL)  -  3 years
Eligibility: One applicant, designated Contact PI, and at least one co-Principal Investigator from two distinct institutions required.
Contact: Linda Nolan (x6071)
Links: Guidelines and Application Instructions
proposalCENTRAL (Submission site)
 

2016 Pancreatic Cancer Action Network -
Research Acceleration Network-2  (RAN-2) Grant

Research in pancreatic cancer that includes a Phase II treatment clinical trial or a robust prevention, detection/diagnosis/prognosis or supportive care trial implemented no later than the beginning of 2nd year of grant term.
Due Dates: Jan. 13 (OSR) Ι Jan. 15 (Sponsor) (Noon, EST)
Amount & Project Period: $2,000,000 (TOTAL)  -  3 years
Eligibility: One applicant, designated Contact  PI, and at least one co-PI from two distinct institutions required
Contact: Linda Nolan (x6071)
Links: Guidelines and Application Instructions                              proposalCENTRAL (Submission site)


January 15 See Below Non-federal Radiologic Science

Research & Education Foundation of the Radiological Society of North America (RSNA)

Due Dates: Jan. 13 (OSR) Ι Jan. 15 (Sponsor)
Contact: Linda Nolan (x6071)

Research Resident/Fellow Grant

Provides trainees not yet professionally established in the radiologic sciences an opportunity to gain further insight into scientific investigation and to develop competence in research techniques and methods.
Amount & Project Period: $30,000 for a 1-year Research Resident project or
$50,000 for a 1-year Research Fellow project.
Eligibility: Minimum of 50% effort on approved research project.
RSNA Member (at any level) at the time of application.
Resident Grant: Must have completed internship year (PGY-1) and at least 6-months of specialty training in the radiologic sciences (PGY-2).
Fellow Grant: Must be in last year of, or have completed, prescribed residency training. If awarded, recipient must be in a fellowship position during period of grant support.
See Details for addnl. Criteria.
Links: Funding Opportunities Ι Details/Application
 

Research Scholar Award

Supports junior faculty members who have completed the conventional resident/fellowship training programs but have not yet been recognized as independent investigators.
Amount & Project Period: $75,000/yr. - 2 years (Intended to secure protected time for recipient; may not be used for non-personnel research expenses.)
Eligibility: Junior faculty w/in 5 years of initial faculty appt. w/academic rank of instructor or assistant professor, (or equivalent) in department of radiology, radiation oncology, or nuclear medicine.
Must be RSNA member.
Requires 40% effort.          
See details for addnl. Criteria.
Links: Funding Opportunities Ι Details-Application
 

Research Seed Grant

Enables investigators to gain experience in defining objectives and testing hypotheses in preparation for major grant applications to corporations, foundations and governmental agencies
Amount & Project Period: $40,000 - 1 year
Eligibility: RSNA Member (at any level) at time of application.
Full-time faculty position in department of radiology, radiation oncology, or nuclear medicine.
Certified by the American Board of Radiology (ABR) or equivalent, or on track for certification.
See Details for addnl. Criteria.
Links: Funding Opportunities Ι  Details/Application
Admin. Supplement NIH
NCI is a participating institute

NEW
January 15 All Ranks Federal Validation Studies - Natural Products

Administrative Supplements to NIH Awards for Validation Studies of Analytical Methods for Natural Products

Support for formal validation studies and publication of relevant quantitative analytical chemistry methods.  Methods must have been developed or utilized in fulfillment of the active parent grant's specific aims.  The NCI Nutritional Science Research Group is particularly interested in validation of quantitative analytical methods for vitamins, minerals, amino acids, putative biologically active botanical constituents, and/or their metabolites, in human or animal specimens that may also be useful indicators of bioavailability, or of particular metabolic, epigenetic, or physiological states.
Due Dates: Jan. 13 (OSR) Ι Jan. 15 (Sponsor)
(Addnl. Due Dates:  Apr. 15 & Oct. 15)
Amount & Project Period: Limited to no more than 25% of direct costs for current budget year of the project or $100,000 (direct costs) whichever is less. 
Must be within the currently approved project period for the existing parent award.  The validation studies proposed for this supplement must be accomplished in 1 year and w/in the competitive segment of the parent award so parent grant must have at least 18 months of active support remaining as of application due date.
Eligibility: IMPORTANT: Research proposed in the supplement application must be w/in the original scope of the NIH-supported grant project.
Validation studies must be conducted in a laboratory that is a participating component of the parent award.  Except in the case of the second laboratory in a two-laboratory validation study, validation studies may not be sub-contracted to a commercial laboratory that was not a participant in the parent award.
Contact: Linda Nolan (x6071)
FOA Link: PA-16-048
U01 NCI
January 17 (LOI) All Faculty Federal Early Detection Etiology

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research

To advance research in cancer etiology and early detection biomarkers, utilizing the biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.  Projects that do not involve the use of PLCO biospecimens will not be supported under this FOA. 
Due Dates: Jan. 17 (Letter of Intent)
Applications due: Feb. 14 (OSR) Ι Feb. 17  (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-297
U2C NIH
Precision Medicine Initiative Cohort  Program through the NIH Office of Strategic Coordination (Common Fund)

NEW
January 17 (LOI) All Ranks Federal Precision Medicine

Precision Medicine Initiative Cohort Program Coordinating Center

The purpose is to provide support for a Coordinating Center for the Precision Medicine Initiative Cohort Program (PMI Cohort Program).  The Coordinating Center (CC) will have the following responsibilities distributed among 3 cores (Administrative, Data, and Research Support):
1. Manage overall project coordination & communications among organizations participating in the PMI Cohort Program.
2. Manage all Direct Volunteer activities, together with the Participant Technologies Center (PTC).
3. Acquire, curate, and provide secure access to the scientific data of the PMI Cohort Program, and provide a set of analysis tools, as well as research support services that enable users to understand how to use the data and analytical tools.
4. Perform data integration across a wide variety of data types, including participant self-report, sensor and app-generated data arriving via the PTC, genomics and other high-throughput laboratory methods, and clinical data from electronic health records (EHRs) systems submitted by healthcare provider organizations (HPOs) and by individuals enrolled as Direct Volunteers. 5. Coordinate testing and Biobank sample submission schedules, and host an administrative and operations core that fosters and evaluates sustained participation in the project by cohort participants over time.
Due Dates: January 17 (Letter of Intent)
Applications Due:  Feb. 15 (OSR) Ι Feb. 17 (Sponsor)
Amount & Project Period: Direct Costs: Year 1: $13.3M; years 2 through 4: $20M;
& year 5: $13.3M
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-PM-16-001
Companion RFA: RFA-PM-16-002, UG3/UH3  Exploratory/Developmental Phased Award Cooperative Agreement




NEW
January 18 Junior Faculty Non-federal Pain

The Rita Allen Foundation & American Pain Society
2016 Award in Pain

Proposed research projects should be directed towards the molecular biology of pain and/or basic science topics related to the development of new analgesics for the management of pain due to terminal illness.
Due Dates: Jan. 16 (OSR) Ι Jan. 18 (Sponsor)
Amount & Project Period: $50,000/yr. - 3 years
Eligibility: Candidate should be in first 3 years of faculty level, tenure-track appointment, and must have received committed start-up funds and independent laboratory space from their institution.
Contact: Linda Nolan (x6071)
Links: Grant Guidelines Ι proposalCENTRAL (Submission Site)






NEW
January 18 (Noon, EST) Junior Faculty Non-federal Career Development

AACR-Triple Negative Breast Cancer Foundation-Carol's Crusade for a Cure Foundation
Career Development Award for Metastatic Triple Negative Breast Cancer Research

To conduct clinical and/or translational cancer research.  Proposed research projects may be in any area of clinical and/or translational cancer research.  Research proposed for funding may be basic, translational, or clinical in nature and must have direct applicability and relevance to metastatic triple negative breast cancer.
Due Dates: Jan. 16 (OSR) Ι Jan. 18 (Sponsor) (Noon, EST)
Amount & Project Period: $83,333/yr. - 3 years
Eligibility: Junior Faculty
Hold full-time, faculty position w/title of assistant professor, instructor, research assistant professor, or equivalent.
     If eligibility is based on a future position, it must be
     confirmed at  time of application, and can NOT be contingent
     upon receiving this grant.
Completed most recent doctoral degree (or medical residency) w/in last 11 years (i.e., degree cannot have been conferred before July 2, 2005).
AACR membership is required; must submit a satisfactory application for AACR Associate Membership by January 18th.
Contact: Linda Nolan (x6071)
Links: 2016 Program Guidelines and Application Instructions
Proposal CENTRAL (Submission Site)


Deadline Extended!
January 22 All Faculty Ranks Non-federal See Below

FORMA Therapeutics,   Inc.
Moffitt Innovative Studies Funding Opportunity - Cycle 2

FORMA and Moffitt wish to leverage their collective expertise and collaborate on research endeavors aimed at improving diagnosis and treatment of patients. Topics should generally fall w/in the broad areas of Epigenetics, Immuno-Oncology, Novel Therapeutic Targets, and Cellular Regulators of Immune Function.
Due Dates: January 22- Extended Deadline
Submit as a single PDF   attachment to Brittany.Palermo@moffitt.org by 4:00 pm EST.
Amount & Project Period: $70,000 - 1 year
Eligibility: All faculty ranks.  May submit 1application as PI; proposals   must be for new projects
Contact: Brittany Palermo (x1536) for updated guidelines & application

NEW
January 22 All Faculty Non-federal Solid Tumors

EMD Serono, a business of Merck KGaA, Darmstadt, Germany
Grant for Oncology Innovation

To advance research on personalized treatment for solid tumors.  Potential research topics which could be funded include: Research on molecular biomarkers or new targeted treatments, technology platforms for the routine analysis of molecular biomarkers, side effect management and platforms or tools which allow patients to access individualized treatment.
Due Dates: Jan. 22  Should you wish to apply, please send a short message to: goi@emdserono.com by this date.
Amount & Project Period: €1,000,000  ($1,507,747 as of 12/7) Duration not stated.
Eligibility: All Faculty
Must be short-term research w/relevance to clinical practice.
Contact: Linda Nolan (x6071)
Links: Welcome to Grant for Oncology Innovation                                       Program Description and Rules
R21 NIH
NCI is a participating institute
NEW
January 25 (LOI) All Ranks Federal Non-communicable Diseases

Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research

NCI's interest is in funding exploratory research along the cancer continuum (prevention, detection, diagnosis, treatment & survivorship) including  well-designed epidemiology studies on common risk factors (social, biological, occupational, environmental) for cancer, use of mobile technologies such mHealth, cancer health disparities/inequities, cancers associated with chronic infections including malignancies in the context of HIV infection, ecological-niche cancers, cancer surveillance including use of cancer registry data for research, and implementation science approaches that analyze ways to achieve economic efficiencies in the management of cancer and translational research.
Due Dates: Jan. 25 (Letter of Intent)
Applications Due: Feb. 22 (OSR) Ι Feb. 24 (Sponsor)
Amount & Project Period: $125,000/yr. (Direct Costs) - Up to 2 years
Eligibility: All Ranks - At least one institution in the U.S. or an UMIC, and at least one institution in a LMIC must be involved as partners in the grant application
Contact:/strong Linda Nolan (x6071)
FOA Link: PAR-16-052
U01 NCI

January 27 All Ranks Federal Tumor Analysis

Proteogenomic Translational Research Centers for Clinical Proteomic Tumor Analysis Consortium

This Funding Opportunity Announcement (FOA) is a part of the NCI Clinical Proteomic Tumor Analysis Consortium (CPTAC).  Applications solicited for multidisciplinary Proteogenomic Translational Research Centers (PTRCs).  PTRCs are intended to function as an interactive group focused on applying standardized state-of-the-art proteomic and genomic approaches to clinically-relevant research projects.
Due Dates: Jan. 25 (OSR) Ι Jan. 27 (Sponsor) (w/letter of intent submitted 30 days prior.) 
Amount & Project Period: May not exceed $910,000/yr. (Direct Costs) - 5 years
Eligibility: Applications must designate at least two PDs/PIs: one expert in proteomics and another expert in clinical trials.
An individual designated as a PD/PI on an application in response to the PGDAC FOA, RFA-15-023, cannot be designated as a PD/PI under this FOA.  However, an individual designated as a PD/PI on an application in response to the PCC FOA RFA-CA-15-021) can be designated as a PD/PI under this FOA
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-022
Companion RFAs: RFA-CA-15-021: Proteome Characterization Centers for Clinical Proteomic Tumor Analysis Consortium (U24)
RFA-CA-15-023:  Proteogenomic Data Analysis Centers for Clinical Proteomic Tumor Analysis Consortium (U24)
R21 NCI

NEW
January 27 (LOI) All Ranks Federal Molecular/Cellular Analysis

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

This RFA solicits applications proposing exploratory research projects focused on early-stage development of highly innovative molecular or cellular analysis technologies for basic or clinical cancer research. The emphasis is on supporting development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology.
Due Dates: Jan. 27 (Letter of Intent)
Applications Due: Feb. 24 (OSR)ΙFeb. 26 (Sponsor)
Amount & Project Period: $400,000 (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-16-001
Companion RFAs: RFA-CA-16-002, Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
RFA-CA-16-003, Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)
RFA-CA-16-004, Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33)

NEW
January 27 (1:00pm, EST) Postdocs Non-federal Career Development

American Brain Tumor Association
Medical Student Summer Fellowship

These Summer Fellowships are intended to support medical students wishing to spend a summer conducting brain tumor research. Fellowship is to be completed over a 12- week period in a neuro-oncology laboratory within a mentorship setting. The goal is to provide an introductory learning experience that will motivate and empower talented medical students by providing them with the skills and knowledge necessary to pursue a career in neuro-oncology research.
Due Dates: Jan. 25 (OSR) Ι Jan. 27 (Sponsor) (1:00pm, EST)
Amount & Project Period: $3,000 - 12 weeks over the course of the summer
Eligibility: Must be currently enrolled in the first, second or third year of medical school.
Must conduct the proposed research and training at the Mentor's institution.
Must not have previously been a fellow on an ABTA Medical Student Summer Fellowship.
Is not required to be a U.S. citizen or resident.
Contact: Linda Nolan (x6071)
Links: RFA Ι ABTA grant portal


 
January 29 Junior Faculty Non-federal Career Development

American Gastroenterological Association
AGA-Caroline Craig Augustyn & Damian Augustyn Award in Digestive Cancer

To support young investigators, instructors, research associates or equivalents conducting research relevant to the pathogenesis, prevention, diagnosis, or treatment of digestive cancer.
Due Dates: Jan. 27 (OSR) Ι Jan. 29 (Sponsor)
Amount & Project Period: $40,000 - 1 year
Eligibility: MD, PhD or equivalent degree w/full time faculty appointment.
Must hold NIH K series or other federal or non-federal career development award of at least 4 years duration and w/at least
1 year left at start of this award.
MD applicants:  < 7 years following completion of clinical training (GI fellowship or its equivalent) at start date of this award.
PhD applicants:  < 7 years following award of PhD at start date
of this award.
AGA membership required
Contact: Linda Nolan (x6071)
Link: Guidelines


January 29 All Ranks Non-federal Pancreatic

The National Pancreas Foundation
Research Grants

Supports funding of research related to pancreatic diseases intended to advance knowledge in pancreatic carcinoma.
Due Dates: Jan. 27 (OSR) Ι Jan. 29 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Link: Research Grants and Awards


NEW
January 29 All Faculty Non-federal Brain Tumors

Southeastern Brain Tumor Foundation
Seed Grants

Funding is awarded for the development of research and clinical trials which will advance technologies and treatments for brain tumor patients; SBTF funds brain tumor research which focuses on curative and clinical applications.
Due Dates: Jan. 27 (OSR) Ι Jan. 29 (Sponsor)
Amount & Project Period: Not exceed $75,000  - 1 year
Eligibility: Faculty holding full-time appointments
Contact: Linda Nolan (x6071)
Link: How to Apply


NEW
January 29 (Noon, EST) Established Faculty Non-federal Pancreatic

Pancreatic Cancer Action Network
Translational Research Grant  

This grant will fund high priority pancreatic cancer research that is poised for important translational next steps in order to help move discovery to application in patients.  To be eligible for consideration, the scientific validation, clinical need and feasibility of developing the proposed clinical modality must already be established and will be required to be presented as part of the application process.
Due Dates: Jan. 27 (OSR) Ι Jan. 29 (Sponsor) (Noon, EST)
Amount & Project Period: $300,000 - 2 years
Eligibility: The project that will qualify for funding will typically benefit from inclusion of cross-disciplinary expertise so applications can include a contact PI or a contact PI and a co-PI.  If two PIs, they should include a basic scientist and a clinician.
Each PI must be an independent researcher w/ a doctoral degree in biomedical sciences or in a field applicable to health science research.
No citizenship requirement, but PI must have a visa status that provides sufficient time to complete the project and the grant term within the U.S.
Contact: Linda Nolan (x6071)  
Links: Guidelines and Application Instructions                                proposalCENTRAL (Submission site)

NEW
January 30 All Ranks Non-federal Pancreatic

The National Pancreas Foundation (NPF)
Research Grants

Research must be in the field of pancreatic diseases.  Studies intended to advance knowledge in the areas of pancreatic carcinoma, and all forms of pancreatitis would be the closest to the areas of interest of the NPF.
Due Dates: Jan. 27 (OSR) Ι Jan. 29 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Links: Research Grants Ι 2016 Grant Application
U10 - Supplement NCI

NEW
January 30 (LOI) See Below Federal Assay Validation

Revision Applications for Assay Validation for High Quality Markers For NCI-Supported Clinical Trials

The purpose is to improve the development and validation of molecular diagnostics for the treatment, control, or prevention of cancer.  This FOA includes, but is not limited to, the validation of prognostic, predictive or response markers for treatment and markers for cancer control or prevention trials.
Due Dates: Jan. 30 (Letter of Intent)
Applications Due: Feb. 27 (OSR) Ι Feb. 29 (Sponsor)
Amount & Project Period: $150,000/yr. (Direct Costs) - up to 2 years, but not to exceed the remaining number of years on the parent grant.
Eligibility: Revision applications will only be accepted to active NIH U10 awardees.  There must be at least two years (24 months) remaining on the project at the estimated time of award
Contact: Linda Nolan (x6071)
FOA Link: PAR-16-056


NEW
January 31 (LOI) All Ranks Non-federal Myelodysplastic Syndromes (MDS)

EvansMDS Strategic Funding Initiatives in Myelodysplastic Syndromes (MDS) Research Grants 2016
Due Dates: Jan. 31 (Letter of Intent)
 Invited Applications:  Apr. 28 (OSR) Ι Apr. 30 (Sponsor)
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Link: Research Grants 2016

 

Discovery Research Grant (DRG)

The focus of these awards will be on transformational basic, translational or aspects of clinical research that are directly applicable to the etiology, pathogenesis or treatment of MDS.
Amount & Project Period: $200,000 - 1 year
  

Translational Research Grant (TRG)

To support a larger scale study that has immediate outcomes for the translation of clinical results and the potential to directly improve MDS patient care. Not intended as the sole funding for a clinical trial, but rather to support ancillary, high-impact correlative studies that will supplement the clinical investigation.
Amount & Project Period: $500,000 - 1 year (Potentially renewable for a 2nd  year)

Programmatic Research Grant (PRG)

This grant is designed to stimulate the development of a highly collaborative and interactive group of investigators studying high value targets in MDS basic, translational or clinical research.  Priority given for programs that have potential to identify new MDS therapies for which the collaborative nature of the research is critical to the proposed aims.
Amount & Project Period: $600,000/yr. - 3 years

NEW
February 01 (LOI) All Ranks Non-federal Breast

Florida Breast Cancer Foundation (FBCF)
2016 Scientific Research Grants

For innovative projects in the areas of: basic, clinical, and translational breast cancer research, epidemiological studies of breast cancer, possible links between breast cancer and the environment, psycho-immunological research and innovative awards, and idea grants.
Due Dates: Feb. 01 (Letter of Intent)
Applications Due: Mar. 14 (OSR) Ι Mar. 16 (Sponsor) Applications must be submitted both electronically and as hardcopy (Hardcopy must be postmarked by March 16).
Amount & Project Period: $200,000  (TOTAL) - 2 years
Eligibility: All Ranks
Proposal must have been previously been submitted to the NIH or DOD during the past 2 calendar years (2014 & 2015) and scored, but not funded.
Contact: Linda Nolan (x6071)
Links: RFA Ι FBCF Ι Research


NEW
February 01 (LOI) Established Faculty Non-federal Career Development

Research Professor Grants

For mid-career investigators who have made seminal contributions that have changed the direction of basic, clinical, psychosocial, behavioral, health policy or epidemiologic cancer research.
Due Dates: February 01 (Letter of Intent)
Upon receipt ACS will provide appropriate guidance either by telephone or email.
Approved Submissions:  March 30 (OSR) Apr. 01 (Sponsor)
Amount & Project Period: $80,000/yr. - 5 years
Eligibility: Applicants will have attained the rank of full professor or equivalent and must not have held the rank of full professor or equivalent for more than 15 years.
Contact: Linda Nolan (x6071)
Links: Research Professor Grants Ι proposalCentral (Submission site)

February 01 All Ranks Non-federal Sarcoma

Sarcoma Foundation of America
Research Grants

The SFA will only accept applications that focus on the following areas of research:
1.  Omic characterization of sarcomas and definition of novel targets.
2.  Omic patterns of sensitivity and resistance to existing agents Systemic therapy combinations. 3.  Immunotherapy.
Due Dates: Jan. 30 (OSR) Ι Feb. 01 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Links: Apply for a Grant Ι proposalCENTRAL (Submission Site)

NEW
February 01 Residents Non-federal Interventional Radiology

Society for Interventional Radiology - The SIR Foundation
Radiology Resident Research Grant

This award is designed to foster an interest in research by funding a research project conducted by the resident in an area identified by SIR Foundation as important to the advancement of interventional radiology and patient care.
Due Dates: Jan. 28 (OSR) Ι Feb. 01 (Sponsor)
Amount & Project Period: Up to $5,000 - 3 months
Eligibility: Residents currently enrolled in an accredited radiology residency training program.
Applicants must be citizens of the United States or Canada or have permanent resident status therein.
Contact: Linda Nolan (x6071)
Links: Guidelines Ι Submission Site
R01 NINR

February 03 (LOI) All Ranks Federal Caregiver Health

Promoting Caregiver Health Using Self-Management

To stimulate research in promoting caregiver health using self-management.  Informal caregivers (lay caregivers) are defined as unpaid individuals (spouses, partners, family members, friends, or neighbors) involved in assisting others with activities of daily living and/or medical tasks.  This concept focuses on informal caregivers.
Due Dates: Feb. 03 (Letter of Intent)
Applications Due:  Mar. 01 (OSR) Ι Mar. 03 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-NR-16-003
R01 NCI

NEW
February 05 All Ranks Federal Treatment-related Cardiotoxicity

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity

This FOA encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity.  The primary intent is to mitigate cardiovascular dysfunction while optimizing cancer outcomes.
Due Dates: Standard dates Ι Feb. 03 (OSR) Ι Feb. 05 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PA-16-035
Companion FOA: PA-16-036 (R21)
Collaborative R01 NCI

NEW
February 05 All Ranks Federal Mammalian Models for T.R.

Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research

The purpose is to solicit applications for collaborative R01 projects from multi-disciplinary teams to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. (No longer limited to mouse models, but expanded to cover any mammalian cancer models.)
Due Dates: Standard dates apply   Ι Feb. 03 (OSR) Ι Feb. 05 (Sponsor)
Amount & Project Period: $450,000/yr. (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-16-058
Companion PAR: PAR-16-059, Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)
R01 NIH
NCI is a participating institute

NEW
February 05 All Ranks Federal Mobile Health Tools

Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention

Supports an expansion of the scope of approved and funded projects to incorporate recent advances in mobile/wireless tools to validate these tools for measurement and intervention delivery. Revision applications for projects that do not currently employ mobile/wireless tools are welcome provided that the applicant team has the requisite scientific and technical expertise to employ and validate these tools.Budgets are not limited - up to 2 years, not to exceed the remaining number of years on the parent grant
Due Dates: Standard dates w/Letter of Intent due 30days prior to proposal submission.
Next application due date:  Feb 03 (OSR) Ι Feb. 05 (Sponsor)
Amount & Project Period:
Eligibility: All Ranks.  If a no-cost extension is needed on parent grant to incorporate the project period of the competitive revision, the no cost extension must be in place before the revision application is submitted.
Contact: Linda Nolan (x6071)
FOA Link: PA-16-043
R01 NCI

February 05 All Ranks Federal Survivorship

Examination of Survivorship Care Planning Efficacy and Impact

To stimulate research evaluating the effect of care planning on self-management of late effects of cancer therapy;  adherence to medications, cancer screening, and health behavior guidelines; utilization of follow-up care; survivors' health and psychosocial outcomes.
Due Dates: Standard dates Feb. 03 (OSR) Ι Feb. 05 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PA-16-012  
Companion FOA: PA-16-011 (R21)
R01 NIH
NCI is a participating institute

                
February 05 All Ranks Federal Multisensory Processing

Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing

NCI supports multisensory research in the context of cancer and cancer control. Topics of interest include:
1) Studies of multisensory interactions w/taste that might govern healthy vs. unhealthy eating, drinking, or smoking;
2) disruption of multisensory perception by cancer and cancer treatments;
3) potential for using multisensory interactions to enhance health communications;
4) multisensory control of attention, as might be relevant in complex oncology or cancer care settings; and
5) circadian and sleep-dependent influences on multisensory interactions. 
NCI will support both human and animal model studies.
Due Dates: Standard dates  Feb. 03 (OSR) Ι Feb. 05 (Sponsor)
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PA-15-347
R01 NINR

February 05 All Ranks Federal Chronic Illness

Personalized Strategies to Manage Symptoms of Chronic Illness

Interdisciplinary research to decrease symptom burden and enhance health-related quality of life (HRQL) in persons with chronic illness through a) increasing knowledge of the biological mechanisms of symptoms, and b) promoting innovative, cost-effective, targeted interventions to prevent, manage or ameliorate these symptoms.
Due Dates: Standard dates Feb. 03 (OSR) Ι Feb. 05 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PA-16-007
Companion FOAs: PA-16-006 (R15)
PA-16-008 (R21)
R01 NINR

February 05 All Ranks Federal Symptom Science & Genomics

Innovative Questions in Symptom Science and Genomics

Initiative seeks to optimize innovation, insight and cutting edge conceptual and technological breakthroughs by catalyzing research that emanates from the identified innovative questions in symptom and genomic nursing science. These innovative questions are reflective of broad domains from which more specific novel hypotheses or problems to be solved can be derived.  
Due Dates: Standard dates Feb. 03 (OSR) Ι Feb. 05 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PA-16-024
Companion FOAs: PA-16-022 (R15)
PA-16-023 (R21)
R01 NCCIH

February 05 All Ranks Federal Metabolomics

Applying Metabolomics to Drive Biomarker Discovery in Symptom Science  

Biomarker discovery utilizing metabolomics approaches to advance the understanding, assessment and management of symptoms
Due Dates: Standard dates Feb. 03 (OSR) Ι Feb. 05 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PA-16-030
Companion FOA: PA-16-029 (R21)

February 12 (LOI) Established Investigators Non-federal See Below

Cancer Research UK
Grand Challenge Awards

Seeking applications from interdisciplinary teams with novel, exciting ways of solving one of seven Grand Challenges:
1.    Develop vaccines to prevent non-viral cancers
2.   Eradicate EBV-induced cancers from the world
3.   Discover how unusual patterns of mutation are induced by different cancer-causing events 4.   Distinguish between lethal cancers that need treating, and non-lethal cancers that do not
5.   Find a way of mapping tumors at the molecular and cellular level
6.   Develop innovative approaches to target cancer super-controller MYC
7.   Deliver biologically active macromolecules to any and all cells in the body
Due Dates: Feb. 12 (Letter of Intent)
Invited Submissions:  Jul. 29 (OSR) Ι Jul.  31 (Sponsor)
Amount & Project Period: £20m - 5 years
Eligibility: Team must have a principal and up to 7 co-investigators; be interdisciplinary; include a patient advocate; and must have a strong UK component w/at least 25% of grant funding spent in the UK .
Contact: Linda Nolan (x6071)
Links: Cancer Research UK  Ι Overview  Ι RFP
February 12 Postdocs Federal Career Development

AHRQ Mentored Clinical Scientist Research Career Development Award

Provides support and protected time to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in health services research.
Due Dates: Standard dates Feb. 10 (OSR) Ι Feb. 12 (Sponsor)
Amount & Project Period: A portion of applicant salary, of up to $90,000 annually plus associated fringe benefits; $25,000 in direct costs per year for the following:  a) related tuition and fees; b) research expenses; c) travel to research meetings or training; d) statistical services.
Eligibility: Candidate must have received a clinical doctoral degree from an accredited domestic or foreign institution.
Must be a citizen or a noncitizen national of the U.S. or have been lawfully admitted for permanent residence.
See FOA for other criteria.
Contact: Linda Nolan (x6071)
Links: PA-13-039 (Expires May 24, 2016)
Admin. Supplement NIH
Common Fund Initiative
February 15 See Below Federal Metabolomics

Collaborative Activities to Promote Metabolomics Research

Supports supplemental funding to current NIH-funded research projects for new interactive collaborations between basic or clinical researchers and metabolomics experts to add a metabolomics approach to the existing Research Strategy of the project.
Due Dates: Feb. 13 (OSR) Ι Feb. 15  (Sponsor)
Amount & Project Period: $100,000 (Direct Costs) -  Maximum of 12 months' funding;
must commence in fiscal year 2016.
Eligibility: Collaborations must be composed of at least one biomedical research investigator and at least one investigator with documented experience in comprehensive metabolomics analyses.
Parent awards must be funded through June 30, 2017, exclusive of any no cost extension.
Only one application per parent award is allowed.
Contact: Linda Nolan (x6071)
FOA Link: PA-16-005
U01 NCI

NEW
February 16 (LOI) All Ranks Federal Small-cell Lung Cancer

Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance

This FOA invites applications to establish research teams of the Small-Cell Lung Cancer (SCLC) Consortium to conduct research whose overall goals are: 1) to improve SCLC therapeutics, focusing on understanding how the molecular vulnerabilities of this cancer could be used to develop targeted agent combinations; and/or, 2) to gain a better understanding of the rapid development of clinical resistance to drug and radiation therapy.
Due Dates: Feb. 16 (Letter of Intent)
Applications Due:  Mar. 15 (OSR) Ι Mar. 17 (Sponsor)
Amount & Project Period: $450,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-16-049
Companion FOAs: PAR-16-050, Small Cell Lung Cancer (SCLC) Consortium: Coordinating Center (U24 )
PAR-16-051, Small-Cell Lung Cancer (SCLC) Consortium: Innovative Approaches to the Prevention and Early Detection of Small Cell Lung Cancer (U01)


NEW
February 16 Junior Investigators Non-federal Career Development

Leukemia Research Foundation
Hollis Brownstein Research Grants Program

This program allows innovative scientists to act on their ideas, and try new procedures and experiments that will hopefully lead to significant breakthroughs.   Preference given to proposals that  focus on leukemia, lymphoma, MDS, and multiple myeloma.
Due Dates: Feb. 14 (OSR) Ι Feb.16 (Sponsor)
Amount & Project Period: $100,000 - 1 year
Eligibility: Must be within seven (7) years of first independent position. (Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years.)
Applicants are not required to be U.S. citizens.
Contact: Linda Nolan (x6071)
Link: Application Information
U24 NIH
NIH Roadmap initiative
February 18 (LOI) All Ranks Federal Physical Activity Omics

Molecular Transducers of Physical Activity Genomics, Epigenomics, and Transcriptomics Chemical Analysis Sites

Awards will support establishment of sites that will use appropriate technology to conduct genomics, epigenomics, and transcriptomics analysis of tissues collected from human participants and animals undergoing a physical activity intervention, contribute that data to a public consortium database, and participate in initial statistical analysis to generate fingerprints of candidate molecular transducers of physical activity.
Due Dates: Feb. 18 (Letter of Intent)
Applications due:  Mar. 16 (OSR) Ι Mar. 18 (Sponsor)
Amount & Project Period: Budgets are limited to direct costs of $50,000 year 01; $3,000,000 year 02; $4,500,000 years 03 through 05; and  $3,500,000 direct costs in year 6.
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-RM-15-010
Companion RFAs:  RFA-RM-15-011, U24 - Molecular Transducers of Physical Activity Metabolomics and Proteomics Chemical Analysis Sites
RFA-RM-15-012, U24 - Molecular Transducers of Physical Activity Bioinformatics Center
RFA-RM-15-013, U01 - Molecular Transducers of Physical Activity Preclinical Animal Study Sites
RFA-RM-15-014, U24 - Molecular Transducers of Physical Activity Consortium Coordinating Center (CCC)
RFA-RM-15-015, U01 - Molecular Transducers of Physical Activity Clinical Centers


NEW
March 01 See Below Non-federal Melanoma

Melanoma Research Foundation
2016 Request for Proposals
Due Dates: Feb. 26 (OSR) Ι Mar. 01 (Sponsor)
Eligibility: See Eligibility Requirements
Contact: Linda Nolan (x6071)
Links: RFP |proposalCENTRAL (Submission Site)

Team Awards

Teams consisting of both basic scientists and clinicians to address an unmet clinical need are encouraged, as is the inclusion of junior scientist. The use of relevant genetic models and/or human derived tumor samples is required.
Amount & Project Period: $250,000/yr. - 2 years
Eligibility: Associate Professor or higher

Established Investigator Awards (EIA)

Support established melanoma researchers, or senior researchers working in closely related fields who wish to move into melanoma research. The use of relevant genetic models and/or human derived tumor samples is highly encouraged.
Amount & Project Period: $100,000/yr. - 2 years
Eligibility: Associate Professor or higher

Career Development Awards (CDA)

Supports junior investigators. Researchers who are beginning a research career focused on melanoma and have not yet established strong federal funding for their research are eligible. The use of relevant genetic models and/or human derived tumor samples is highly encouraged.
Amount & Project Period: $50,000/yr. - 2 years
Eligibility: Postdocs w/less than 5 years of experience; junior faculty may be research associates or assistant professors

CURE OM Junior Fellowship Award

Focused on ocular melanoma.
Amount & Project Period: $50,000/yr. - 2 years
Eligibility: Junior Faculty

CURE OM Unite! Established Investigator Award

For an established ocular melanoma researcher to bridge the gap between patients and researchers. This unique opportunity will include a patient review panel in addition to the MRF's standard, expert, peer-reviewed panel, allowing the patient perspective to be considered in the critique process.
Amount & Project Period: $100,000/yr. - 2 years
Eligibility: Established ocular melanoma researcher

Medical Student Awards

 Provides opportunities and funding for medical students to engage in short clinical or laboratory-based research projects focused on better understanding the biology and treatment of melanoma. The grant application process is through a separate award mechanism; additional details are available here.
Amount & Project Period: $3,000 - 12 months
Eligibility: Medical students at accredited U.S. medical schools or institutions
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org